课题基金 / 基金详情

Development of Autoimmune Disease Models Based on FcyRIIB-Deficient Mice

Development of Autoimmune Disease Models Based on FcyRIIB-Deficient Mice
基于FcyRIIB缺陷小鼠的自身免疫性疾病模型的开发
批准号:
12557014
负责人:
TAKAI Toshiyuki
金额:
$7.55万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

TAKAI Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The receptors for Fc protion of immunoglobulins, Fc receptors (FcRs), combine innate and adaptive immunity and are critical elements to activate or down-modulate the immune responses. Activity of various cells in the immune system is intimately regulated by the balanced signaling through FcRs. Development of many autoimmune diseases in humans may now be interpreted by the impairement in the FcR regulatory system. To address the question whether the type IIB Fc receptor for IgG (FcγRIIB)-deficient mice (RIIB-/-) are susceptible to induction of various autoimmune diseases, we tested to induce type II collagen-induced arthritis (CIA), a model for rheumatoid arthritis in humans. We found that RIIB-/- on a non-permissive H-2b background become susceptible to CIA induction. Moreover, we could induce Goodpasture' s syndrome (GPS) in RIIB-/- by immunization with type IV collagen. Quite similar to human GPS, RIIB-/- develop massive pulmonary hemorrhage and glomerulonephritis. These results highlight the role of FcγRIIB in maintaining tolerance and suggest that it may play a critical role in the pathogenesis of rheumatoid arthritis and GPS in humans.
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
Kubo, S., Matsuoka, K., Taya, C., Kitamura, F., Takai, T., Yonekawa, H., Karasuyama, H.: "Drastic up-regulation of FcεRI on mast cells is induced by IgE binding through stabilization and accumulation of FcεRI on the cell surface"J. Immunol.. 167 (6). 3427
Kubo, S.、Matsuoka, K.、Taya, C.、Kitamura, F.、Takai, T.、Yonekawa, H.、Karasuyama, H.:“IgE 结合诱导肥大细胞上 FcεRI 的急剧上调通过 FcεRI 在细胞表面的稳定和积累”J.Immunol..167(6).3427
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Schiller, C., Janssen-Graalfs, I., Baumann, U., Schwerter-Strumpf, K., Izui, S., Takai, T., Schmidt, R.E., and Gessner, J.E.: "Mouse FcγRII is a negative regulator of FcγRIII in IgG immune complex triggered inflammation but not in antoantibody induced hem
Schiller, C.、Janssen-Graalfs, I.、Baumann, U.、Schwerter-Strumpf, K.、Izui, S.、Takai, T.、Schmidt, R.E. 和 Gessner, J.E.:“小鼠 FcγRII 是负调节因子IgG 免疫复合物中的 FcγRIII 会引发炎症,但不会引发抗体诱导的炎症
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
2.Lee,K.H., et al: "Stimulatory function of gp49A, a murine Ig-like receptor, in RBL-2H3 cells."J.Immunol.. 165. 4970-4977 (2000)
2.Lee,K.H.等人:“RBL-2H3细胞中鼠类Ig样受体gp49A的刺激功能。”J.Immunol.. 165. 4970-4977 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
4.Kaji,K., et al.: "Functional association of CD9 molecule with FCγIII receptor in macrophages."J.Immunol.. 166. 3256-3265 (2001)
4.Kaji, K., et al.:“巨噬细胞中 CD9 分子与 FCγIII 受体的功能关联。J.Immunol.. 166. 3256-3265 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
31
    Mechanism of LILRB4-mediated immune checkpoint
    • 批准号:
      19H03484
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2019
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    Modulating immunological memory of antibody-producing cells
    • 批准号:
      17K19539
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2017
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    Identification of molecular characteristics of pathogenic autoantibody-producing cells
    • 批准号:
      16H05201
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2016
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    Platelets convert peripheral blood circulating monocytes to regulatory cells via immunoglobulin G and activating-type Fcg receptors.
    • 批准号:
      26670230
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2014
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    海外基金